Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by steadfaston Jun 03, 2014 2:05pm

251 Views

Post# 22625685

RE:a QUESTION FOR NOPOO

1. I have come up with answers to #1 and #2. As the first two patients were part of the clinical
trial 1, and that trial is over, the cellpouch would have to be removed, legally, as it has yet
to be approved.
2. SVA do now have 3 experienced people to get a Business Development Partner once
efficacy results are proven and released. I expect they must be out making contacts now
so things can progress quickly once results are released.
3. We just have to be patient til results released. These 3 big hitters would not have come
on board, if they did not feel confident of results.
4. I still need to understand about islets survival in Trial #2 - how long has it been since
transplanted?

Bullboard Posts

The top TSX healthcare stocks under $1